Author/Authors :
Çayır, Derya University of Health Sciences - Dışkapı Yıldırım Beyazıt Training and Research Hospital - Clinic of Nuclear Medicine - Ankara, Turkey , Arazm, Mine University of Health Sciences - Dışkapı Yıldırım Beyazıt Training and Research Hospital - Clinic of Nuclear Medicine - Ankara, Turkey , Akın, Şafak University of Health Sciences - Dışkapı Yıldırım Beyazıt Training and Research Hospital - Clinic of Endocrinology and Metabolism - Ankara, Turke , Karaköse, Melia University of Health Sciences - Dışkapı Yıldırım Beyazıt Training and Research Hospital - Clinic of Endocrinology and Metabolism - Ankara, Turke , Çakal, Erman University of Health Sciences - Dışkapı Yıldırım Beyazıt Training and Research Hospital - Clinic of Endocrinology and Metabolism - Ankara, Turke
Abstract :
Tc-99m-methylene diphosphonate (MDP) whole body scintigraphy is the method of choice for detection of metastatic bone diseases. It is primarily used to help diagnose various bone-related conditions such as primary or metastatic cancer of the bone, location of bone inflammation, and fractures that may not be visible on traditional X-ray images, as well as detection of bone damage due to infections and other conditions. In addition, bone scanning is often used for the follow-up or evaluation of response to treatment in some malignancies like prostate and breast cancers. Pathologies of other systems can also be incidentally detected on whole body bone scan. Herein we present an interesting image of an active thyroid nodule that showed Tc-99m MDP uptake in a prostate cancer patient.
